ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $610,023 | -9.9% | 38,318 | -7.4% | 0.03% | -27.5% |
| Q3 2022 | $677,000 | -66.9% | 41,394 | -71.5% | 0.04% | -71.0% |
| Q2 2022 | $2,047,000 | -41.8% | 145,289 | 0.0% | 0.14% | -20.2% |
| Q1 2022 | $3,519,000 | -32.9% | 145,289 | -35.4% | 0.17% | -28.8% |
| Q4 2021 | $5,248,000 | +52.4% | 224,830 | +8.5% | 0.24% | +53.8% |
| Q3 2021 | $3,443,000 | +15.9% | 207,284 | +70.2% | 0.16% | +19.7% |
| Q2 2021 | $2,971,000 | +32.2% | 121,802 | +39.8% | 0.13% | +33.3% |
| Q1 2021 | $2,247,000 | +5.5% | 87,111 | +118.7% | 0.10% | -18.9% |
| Q4 2020 | $2,129,000 | – | 39,823 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |